Stocks and Investing Stocks and Investing
Tue, March 5, 2024

Vamil Divan Maintained (ANIP) at Strong Buy with Increased Target to $77 on, Mar 5th, 2024


Published on 2024-10-28 09:27:23 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Guggenheim, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $70 to $77 on, Mar 5th, 2024.

Vamil has made no other calls on ANIP in the last 4 months.



There are 2 other peers that have a rating on ANIP. Out of the 2 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vamil


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $83 on, Monday, March 4th, 2024
  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Friday, March 1st, 2024
Contributing Sources